Improved detection of recurrent bladder cancer using the bard bta stat test
Authors:
- M'LIss A. HudsonMHM'LIss A. Hudson
- William J. EllisWEWilliam J. Ellis
- Mark S. SolowayMSMark S. Soloway
- Ralph Devere WhiteRWRalph Devere White
- Joel SheinfeldJSJoel Sheinfeld
- Mark V. JarowenkoMJMark V. Jarowenko
- Paul F. SchellhammerPSPaul F. Schellhammer
- Ed W. SchervishESEd W. Schervish
- Jay V. PatelJPJay V. Patel
- Gerald W. ChodakGCGerald W. Chodak
- Donald L. LammDLDonald L. Lamm
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical TreatmentJournal of Urology, 1996
- Initial Evaluation of the Bladder Tumor Antigen Test in Superficial Bladder CancerJournal of Urology, 1996
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Evaluation of Bladder Washings and Urine Cytology in the Diagnosis of Bladder Cancer and Its Correlation with Selected Biopsies of the Bladder MucosaJournal of Urology, 1984
- Number of observations required for the comparison of two correlated proportionsCommunications in Statistics - Simulation and Computation, 1980